UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 242

Sortiert nach

Multi‐trial, aggregated, individual participant data mega‐analysis of short‐term antidepressant versus mood stabilizer monotherapy of bipolar type II major depressive episode

Bipolar disorders, 2024-05, Vol.26 (3), p.255-264

2024

Volltextzugriff (PDF)

Efficacy and Safety of Long-Term Fluoxetine Versus Lithium Monotherapy of Bipolar II Disorder: A Randomized, Double-Blind, Placebo-Substitution Study

The American journal of psychiatry, 2010-07, Vol.167 (7), p.792-800

2010

Volltextzugriff (PDF)

Antidepressant drug effects and depression severity: a patient-level meta-analysis

JAMA : the journal of the American Medical Association, 2010-01, Vol.303 (1), p.47

2010

Volltextzugriff (PDF)

Relative effectiveness of tricyclic antidepressant versus monoamine oxidase inhibitor monotherapy for treatment-resistant depression

Journal of affective disorders, 2019-05, Vol.250, p.199-203

2019

Volltextzugriff (PDF)

Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial

Phytomedicine (Stuttgart), 2016-12, Vol.23 (14), p.1735-1742

2016

Volltextzugriff (PDF)

Prediction of Response to Medication and Cognitive Therapy in the Treatment of Moderate to Severe Depression

Journal of consulting and clinical psychology, 2009-08, Vol.77 (4), p.775-787

2009

Volltextzugriff (PDF)

Rhodiola rosea L. as a putative botanical antidepressant

Phytomedicine (Stuttgart), 2016-06, Vol.23 (7), p.770-783

2016

Volltextzugriff (PDF)

Effectiveness and safety of monoamine oxidase inhibitor treatment for bipolar depression versus unipolar depression: An exploratory case cohort study

Acta psychiatrica Scandinavica, 2023-02, Vol.147 (2), p.198-204

2023

Volltextzugriff (PDF)

Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial

JAMA psychiatry (Chicago, Ill.), 2014-10, Vol.71 (10), p.1157

2014

Volltextzugriff (PDF)

Effects of venlafaxine versus lithium monotherapy on quality of life in bipolar II major depressive disorder: Findings from a double-blind randomized controlled trial

Psychiatry research, 2018-01, Vol.259, p.455-459

2018

Volltextzugriff (PDF)

Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical Trial

JAMA psychiatry (Chicago, Ill.), 2020-03, Vol.77 (3), p.237

2020

Volltextzugriff (PDF)

What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STARD study’s patient-level data with fidelity to the original research protocol

BMJ open, 2023-07, Vol.13 (7), p.e063095-e063095

2023

Volltextzugriff (PDF)

Prior Antidepressant Treatment Trials May Predict a Greater Risk of Depressive Relapse During Antidepressant Maintenance Therapy

Journal of clinical psychopharmacology, 2019-07, Vol.39 (4), p.344

2019

Volltextzugriff (PDF)

Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder

Phytomedicine (Stuttgart), 2016-12, Vol.23 (14), p.1699-1705

2016

Volltextzugriff (PDF)

Relative Effectiveness of Monoamine Oxidase Inhibitor and Tricyclic Antidepressant Combination Therapy for Treatment-Resistant Depression

Journal of clinical psychopharmacology, 2019-11, Vol.39 (6), p.649

2019

Volltextzugriff (PDF)

Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: Effectiveness and mood conversion rate

British journal of psychiatry, 2016-04, Vol.208 (4), p.359-365

2016

Volltextzugriff (PDF)

Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study

Journal of affective disorders, 2015-10, Vol.185, p.31-37

2015

Volltextzugriff (PDF)

A Randomized, Double-Blind, Placebo-Controlled Trial of Oral Matricaria recutita (Chamomile) Extract Therapy for Generalized Anxiety Disorder

Journal of clinical psychopharmacology, 2009-08, Vol.29 (4), p.378-382

2009

Volltextzugriff (PDF)

Residual anxiety may be associated with depressive relapse during continuation therapy of bipolar II depression

Journal of affective disorders, 2018-02, Vol.227, p.379-383

2018

Volltextzugriff (PDF)

Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial

Phytomedicine (Stuttgart), 2015-03, Vol.22 (3), p.394-399

2015

Volltextzugriff (PDF)

Two Aspects of the Therapeutic Alliance: Differential Relations with Depressive Symptom Change

Journal of consulting and clinical psychology, 2011-06, Vol.79 (3), p.279-283

2011

Volltextzugriff (PDF)

Greater striatal dopamine transporter density may be associated with major depressive episode

Journal of affective disorders, 2012-12, Vol.141 (2), p.425-431

2012

Volltextzugriff (PDF)

Step-wise loss of antidepressant effectiveness with repeated antidepressant trials in bipolar II depression

Bipolar disorders, 2016-11, Vol.18 (7), p.563-570

2016

Volltextzugriff (PDF)

Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder

British journal of psychiatry, 2013-04, Vol.202 (4), p.301-306

2013

Volltextzugriff (PDF)

Specific Pharmacological Effects of Paroxetine Comprise Psychological but Not Somatic Symptoms of Depression

PloS one, 2016-07, Vol.11 (7), p.e0159647-e0159647

2016

Volltextzugriff (PDF)

1 – 25 von 242

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(218)
Mit Volltextzugriff
(198)

Publikationsform

Artikel
(239)
Reviews
(3)

Sprache

Englisch
(242)
Japanisch
(19)
Polnisch
(3)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(181)
Science & Technology
(170)
Life Sciences & Biomedicine
(169)
Psychiatry
(154)
Female
(147)
Adult
(145)
Male
(144)
Biological And Medical Sciences
(114)
Medical Sciences
(112)
Middle Aged
(111)
Psychology. Psychoanalysis. Psychiatry
(102)
Pharmacology. Drug Treatments
(77)
Depression
(76)
Neuropharmacology
(71)
Psychopharmacology
(71)
Treatment Outcome
(70)
Psychopathology. Psychiatry
(66)
Psychoanaleptics: Cns Stimulant, Antidepressant Agent, Nootropic Agent, Mood Stabilizer...,
(64)
Neurosciences & Neurology
(61)
Double-Blind Method
(52)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multi‐trial, aggregated, individual participant data mega‐analysis of short‐term antidepressant versus mood stabilizer monotherapy of bipolar type II major depressive episode

Efficacy and Safety of Long-Term Fluoxetine Versus Lithium Monotherapy of Bipolar II Disorder: A Randomized, Double-Blind, Placebo-Substitution Study

Antidepressant drug effects and depression severity: a patient-level meta-analysis

Relative effectiveness of tricyclic antidepressant versus monoamine oxidase inhibitor monotherapy for treatment-resistant depression

Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial

Prediction of Response to Medication and Cognitive Therapy in the Treatment of Moderate to Severe Depression

Rhodiola rosea L. as a putative botanical antidepressant

Effectiveness and safety of monoamine oxidase inhibitor treatment for bipolar depression versus unipolar depression: An exploratory case cohort study

Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial

Effects of venlafaxine versus lithium monotherapy on quality of life in bipolar II major depressive disorder: Findings from a double-blind randomized controlled trial

Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical Trial

What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STARD study’s patient-level data with fidelity to the original research protocol

Prior Antidepressant Treatment Trials May Predict a Greater Risk of Depressive Relapse During Antidepressant Maintenance Therapy

Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder

Relative Effectiveness of Monoamine Oxidase Inhibitor and Tricyclic Antidepressant Combination Therapy for Treatment-Resistant Depression

Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: Effectiveness and mood conversion rate

Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study

A Randomized, Double-Blind, Placebo-Controlled Trial of Oral Matricaria recutita (Chamomile) Extract Therapy for Generalized Anxiety Disorder

Residual anxiety may be associated with depressive relapse during continuation therapy of bipolar II depression

Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial

Two Aspects of the Therapeutic Alliance: Differential Relations with Depressive Symptom Change

Greater striatal dopamine transporter density may be associated with major depressive episode

Step-wise loss of antidepressant effectiveness with repeated antidepressant trials in bipolar II depression

Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder

Specific Pharmacological Effects of Paroxetine Comprise Psychological but Not Somatic Symptoms of Depression

Suchergebnisse filtern